Advanced Search

National Health Act 1953 - Determinations under sections 93 and 93AA - Pharmaceutical benefits supplied by medical practitioners and authorised nurse practitioners (No. PB 103 of 2010)

Subscribe to a Global-Regulation Premium Membership Today!

Key Benefits:

Subscribe Now for only USD$40 per month.
 
 
COMMONWEALTH OF AUSTRALIA
Instrument number PB 103 of 2010
Determinations under sections 93 and 93AA of the National Health Act 1953
I, DAVID LEARMONTH, Deputy Secretary, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this instrument under sections 93 and 93AA of the National Health Act 1953.
 
Dated 29th October 2010
 
 
 
 
 
DAVID LEARMONTH
Deputy Secretary
Department of Health and Ageing
 
 
Determinations — Pharmaceutical benefits supplied by medical practitioners and authorised nurse practitioners
1.   Name of Instrument
            (a)     The name of this Instrument is Determinations under sections 93 and 93AA of the National Health Act 1953.
         (b)     This Instrument may also be cited as “No. PB 103 of 2010”.
2.   Commencement
This Instrument commences on 1 November 2010.
3.   Repeal
Determination No. PB 57 of 2007 under section 93 of the National Health Act 1953, made on 24 July 2007 with effect from 1 August 2007 (as amended) is repealed.
4.   Definitions
In this Instrument:
“Act” means the National Health Act 1953;
“authorised nurse practitioner” has the meaning given by subsection 84(1) of the Act.
5.   Pharmaceutical benefits
A pharmaceutical benefit which has a listed drug in a form mentioned in the Schedule is a pharmaceutical benefit which a medical practitioner and an authorised nurse practitioner is authorised to supply.
 
6.   Maximum quantity or number of units
The maximum quantity or number of units of a pharmaceutical benefit which may be obtained by a medical practitioner or authorised nurse practitioner in any period of one month is the quantity or number of units mentioned in the Schedule under the column “maximum quantity” for the listed drug in the form mentioned less the quantity or number of units of the pharmaceutical benefit previously obtained in accordance with sections 93 and 93AA of the Act and still in the possession of the medical practitioner or authorised nurse practitioner.
 

Adrenaline
Injection 1 mg (as acid tartrate) in 1 mL (1 in 1,000)
5

Atropine
Injection containing atropine sulfate 600 micrograms in 1 mL
10

Benztropine
Injection containing benztropine mesylate 2 mg in 2 mL
5

Benzylpenicillin
Powder for injection 600 mg (as sodium)
10

OR
 
 

Procaine Penicillin
Injection 1.5 g in disposable syringe
5

Benzylpenicillin
Powder for injection 3 g (as sodium)
1

Chlorpromazine
Injection containing chlorpromazine hydrochloride 50 mg in 2 mL
10

OR
 
 

Haloperidol
Injection 5 mg in 1 mL
10

Clonazepam
Oral liquid 2.5 mg per mL, 10 mL
1

Dexamethasone
Injection containing dexamethasone sodium phosphate equivalent to 4 mg dexamethasone phosphate in 1 mL
5

OR
 
 

Hydrocortisone
Injection 100 mg (as sodium succinate) with 2 mL solvent
2

OR
 
 

Hydrocortisone
Injection 250 mg (as sodium succinate) with 2 mL solvent
1

Diazepam
Injection 10 mg in 2 mL
5

Dihydroergotamine
Injection containing dihydroergotamine mesylate 1 mg in 1 mL
5

Diphtheria and tetanus vaccine, adsorbed, diluted for adult use
Injection 0.5 mL in pre-filled syringe
20

Frusemide
Injection 20 mg in 2 mL
5

Glucagon
Injection set containing glucagon hydrochloride 1 mg (1 I.U.) and 1 mL solvent in disposable syringe
1

Glyceryl Trinitrate
Sublingual spray (pump pack) 400 micrograms per dose, 200 doses
1

Hyoscine
Injection containing hyoscine butylbromide 20 mg in 1 mL
5

Lignocaine
Injection containing lignocaine hydrochloride 100 mg in 5 mL
5

Metoclopramide
Injection containing metoclopramide hydrochloride 10 mg in 2 mL
10

OR
 
 

Prochlorperazine
Injection containing prochlorperazine mesylate 12.5 mg in 1 mL
10

Morphine
Injection containing morphine sulfate 15 mg in 1 mL
5

OR
 
 

Morphine
Injection containing morphine sulfate 30 mg in 1 mL
5

Naloxone
Injection containing naloxone hydrochloride 2 mg in 5 mL disposable injection set
2

Promethazine
Injection containing promethazine hydrochloride 50 mg in 2 mL
10

Salbutamol
Pressurised inhalation 100 micrograms (as sulfate) per dose, 200 doses (CFC-free formulation)
1

OR
 
 

Salbutamol
Nebuliser solution 2.5 mg (as sulfate) in 2.5 mL single dose units, 30
1

Salbutamol
Nebuliser solution 5 mg (as sulfate) in 2.5 mL single dose units, 30
1

Terbutaline
Injection containing terbutaline sulfate 500 micrograms in 1mL
5

Tramadol
Injection containing tramadol hydrochloride 100 mg in 2 mL
5

Verapamil
Injection containing verapamil hydrochloride 5 mg in 2 mL
5

 
_________________________________________________________________________________
Note
All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003. 
See http://www.frli.gov.au.